Cardiovascular events in thyroid disease: A population based, prospective study

Hormone and Metabolic Research

Volumn 43, Issue 9, 2011, Pages 653-659

  Schultz, M ^a   Kistorp, C ^a   Raymond, I ^a   Dimsits, J ^a   Tuxen, C ^a   Hildebrandt, P ^a   Faber, J ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

CV risk; NT proBNP; stroke; subclinical thyroid diseases; TSH

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; THYROTROPIN;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DENMARK; EUTHYROIDISM; FEMALE; FOLLOW UP; GENERAL PRACTICE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; STROKE; THYROID DISEASE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; THYROID DISEASES; THYROTROPIN;

EID: 80051791019     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1283162     Document Type: Review

References (46)

1. Cooper DS. Approach to the Patient with Subclinical Hyperthyroidism. J Clin Endocrinol Metab: 2007; 92 3 9
2. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med: 2001; 344 501 509 (Pubitemid 32164903)
3. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol: 2007; 49 71 81 (Pubitemid 46026889)
4. Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol: 2001; 145 391 396 (Pubitemid 32927063)
5. Klein I, Levey GS. The cardiovascular system in thyrotoxicosis. In: Braverman LE, Utiger RD. ed Werner and Ingbars The Thyroid. Philadelphia Lippincott-Raven Publisher: 1996; 607 615
6. Faber J, Petersen L, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid: 2002; 12 319 324 (Pubitemid 34438936)
7. Klein I, Ojamaa K. The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD. ed Werner and Ingbars The Thyroid. Philadelphia Lippincott-Raven Publisher: 1996; 799 804
8. Wang C, Crapo LM. The epidemiology of thyroid disease and implication for screening. Endocrinol Metab Clin North Am: 1997; 26 189 218 (Pubitemid 27123901)
9. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid: 1998; 8 803 813 (Pubitemid 28535693)
10. Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am: 1998; 27 37 49 (Pubitemid 28144952)
11. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med: 2002; 137 904 914 (Pubitemid 35416626)
12. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in elderly in the United Kingdom. Clin Endocrinol (Oxf): 1991; 34 77 83
13. Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med: 1991; 78 77 84
14. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med: 1991; 151 165 168
15. Sundbeck G, Jagenburg R, Johansson PM, Eden S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med: 1991; 151 549 556
16. Forfar JC, Muir AL, Sawer SA, Toft AD. Abnormal left ventricular function in hyperthyroidism. Evidence for possible reversible cardiomyopathy. N Engl J Med: 1982; 307 1165 1170 (Pubitemid 12037975)
17. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D, Nicoloff JT. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab: 1990; 70 453 460
18. Davis PH, Franklyn JA, Daykin J, Sheppard MC. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. J Clin Endocrinol Metab: 1992; 74 1189 1194
19. Raymond I, Pedersen F, Busch-Srensen M, Green A, Hildebrandt PR. The Frederiksberg Heart Failure Study: Rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population. HeartDrug: 2002; 4 67 174
20. Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. In: World Health Organisation Monograph series. Geneva World Health Organization (ed. 2): 1982; 56
21. Karl J, Borgya A, Gallusser A, Huber E, Krueger K, Rollinger W, Schenk J. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest: 1999; 230 177 181 (Pubitemid 29279370)
22. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. J Am Med Assoc: 2005; 293 1609 1616 (Pubitemid 40471791)
23. Richards AM, Troughton R, Lainchbury J, Doughty R, Wright S. 2005;Guiding and Monitorering of Heart Failure Therapy with NT-ProBNP: Concepts and Clinical Studies. J Card Fail: 2005; 11 S34 S37
24. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull: 1999; 46 263 268 (Pubitemid 29299976)
25. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, DAgostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med: 1994; 331 1249 1252 (Pubitemid 24333188)
26. Presti C, Hart RG. Thyrotoxicosis atrial fibrillation and embolism, revisited. Am Heart J: 1989; 117 976 977 (Pubitemid 19097310)
27. Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J: 1977; 2 688 690 (Pubitemid 8174261)
28. Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med: 1981; 141 1191 1192 (Pubitemid 11017504)
29. Squizzato A, Gerdes VE, Brandjes DP, Buller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke: 2005; 36 2302 2310 (Pubitemid 41429267)
30. Tenerz A, Forberg R, Jansson R. 1990;Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med: 1990; 228 229 233 (Pubitemid 20330723)
31. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J: 2001; 142 838 842 (Pubitemid 33016203)
32. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. J Am Med Assoc: 2006; 295 1033 1041
33. Hoogendoorn EH, den Heijer M, van Dijk AP, Hermus AR. Subclinical hyperthyroidism: to treat or not to treat? Postgrad Med J: 2004; 80 394 398
34. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet: 2001; 358 861 865 (Pubitemid 32900566)
35. Gussekloo J, Exel EV, AJMD Craen, Meinders AE, Frlich M, Westerndorp RGJ. Thyroid status, disability and cognitive function, and survival in old age. J Am Med Assoc: 2004; 292 2591 2599 (Pubitemid 39577515)
36. Walsh JP, Bremner AP, Bulsara MK, OLeary P, Leedman PJ, Feddema P, Michelangeli V. Subclinical Thyroid Dysfunction as a Risk Factor for Cardiovascular Disease. Arch Intern Med: 2005; 165 2467 2472 (Pubitemid 41720007)
37. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis. Am J Med: 2006; 119 541 551 (Pubitemid 44041257)
38. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witterman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med: 2000; 132 270 278 (Pubitemid 30106257)
39. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab: 2004; 89 3365 3370 (Pubitemid 38951905)
40. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol: 2004; 61 232 238 (Pubitemid 39093119)
41. Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M, Fox KA, Toft AD. Thyroid Disease and Increased Cardiovascular Risk. Thyroid: 2005; 15 718 724 (Pubitemid 41117525)
42. Col NF, Surks MI, Daniels GH. Subclinical Thyroid Disease: Clinical Applications. J Am Med Assoc: 2004; 291 239 243 (Pubitemid 38082819)
43. Schultz M, Faber J, Kistorp C, Jarlov A, Pedersen F, Wiinberg N, Hildebrandt P. N-terminal-pro-b-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol (Oxf): 2004; 60 54 59 (Pubitemid 38183498)
44. Schultz M, Kistorp C, Langdahl B, Raymond I, Hildebrandt P, Faber J. N-terminal-pro-b-type natriuretic peptide in acute hyperthyroidism. Thyroid: 2007; 17 237 241 (Pubitemid 46557372)
45. Biondi B, Cooper DS. The Clinical Significance in Subclinical Thyroid Dysfunction. Endocr Rev: 2008; 29 76 131 (Pubitemid 351252748)
46. Knudsen N, Blow I, Jrgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol: 2000; 143 485 491